Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company offers OTC products, such as external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. It also exports its products to Asia, the United States, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. As of February 19, 2026, Hisamitsu Pharmaceutical Co., Inc. operates as a subsidiary of Taiyo Kosan Co., Ltd.
Frequently asked questions
What sector does Hisamitsu Pharmaceutical Inc (4530) operate in?
Hisamitsu Pharmaceutical Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Hisamitsu Pharmaceutical Inc (4530) current stock price?
As of the latest data, Hisamitsu Pharmaceutical Inc stock price is ¥6,040, with a previous close of ¥6,040.
What is Hisamitsu Pharmaceutical Inc (4530) current market capitalization?
Hisamitsu Pharmaceutical Inc market cap is approximately 425.23 billion.
What is Hisamitsu Pharmaceutical Inc (4530) Earnings Per Share (EPS)?
The trailing EPS is ¥269, and the forward EPS is ¥226.
What is Hisamitsu Pharmaceutical Inc (4530) Price-to-Earnings (P/E) ratio?
Hisamitsu Pharmaceutical Inc current P/E ratio is 22.47, with a forward P/E of 26.71.
Does Hisamitsu Pharmaceutical Inc (4530) pay dividends?
No. Hisamitsu Pharmaceutical Inc does not pay a dividend.
What is Hisamitsu Pharmaceutical Inc (4530) beta (volatility) score?
Hisamitsu Pharmaceutical Inc has a beta of 0.291, indicating lower volatility than the overall market.
